Send me a link:

*Text messaging rates may apply.

 Dow Down0.52% Nasdaq Down0.93%

Acura Pharmaceuticals, Inc. (ACUR)

-NasdaqCM
1.04 Up 0.03(2.97%) Jul 30 - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingMar 31, 2014Dec 31, 2013Sep 30, 2013Jun 30, 2013
Total Revenue 42   35   83   1  
Cost of Revenue38  36  78   -  
Gross Profit 4   (1) 5   1  
Operating Expenses
Research Development1,438  803  1,289  805  
Selling General and Administrative2,259  2,427  1,941  2,336  
Non Recurring133  250   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,826) (3,481) (3,225) (3,140)
Income from Continuing Operations
Total Other Income/Expenses Net39  73  35  64  
Earnings Before Interest And Taxes(3,787)(3,408)(3,190)(3,076)
Interest Expense301  9   -   -  
Income Before Tax(4,088)(3,417)(3,190)(3,076)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops(4,088)(3,417)(3,190)(3,076)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income (4,088) (3,417) (3,190) (3,076)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares (4,088) (3,417) (3,190) (3,076)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.